A Controlled Randomized Open-label Multicenter Study Evaluating if Early Conversion to Everolimus From Cyclosporine in de Novo Renal Transplant Recipients Can Improve Long-term Renal Function and Slow Down the Progression of Chronic Allograft Nephropathy
Interventional
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment
Renal function measured by Iohexol or Cr EDTA (Crom Ethylenediaminotetra acetate) clearance at randomization after 12 and 36 months
12 and 36 months
No
Sweden: Medical Products Agency
CRAD001ASE01
NCT00634920
March 2008
Name | Location |
---|